Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation

Hung Nguyen, Hoang Linh Nguyen, Pham Dang Lan, Nguyen Quoc Thai, Mateusz Sikora and Mai Suan Li

Chem. Soc. Rev., 2023, 52, 6497
DOI: 10.1039/D1CS01170G

Rationale for combined therapies in severe-to-critical COVID-19 patients

Aitor Gonzaga, Etelvina Andreu, Luis M. Hernández-Blasco, Rut Meseguer, Karima Al-Akioui-Sanz, Bárbara Soria-Juan, Jose Carlos Sanjuan-Gimenez, Cristina Ferreras, Juan R. Tejedo, Guillermo Lopez-Lluch, Rosa Goterris, Loreto Maciá, Jose M. Sempere-Ortells, Abdelkrim Hmadcha, Alberto Borobia, Jose L. Vicario, Ana Bonora, Cristobal Aguilar-Gallardo, Jose L. Poveda, Cristina Arbona, Cristina Alenda, Fabian Tarín, Francisco M. Marco, Esperanza Merino, Francisco Jaime, José Ferreres, Juan Carlos Figueira, Carlos Cañada-Illana, Sergio Querol, Manuel Guerreiro, Cristina Eguizabal, Alejandro Martín-Quirós, Ángel Robles-Marhuenda, Antonio Pérez-Martínez, Carlos Solano and Bernat Soria

Front. Immunol., 2023, 14
DOI: 10.3389/fimmu.2023.1232472

In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants

Calvin R. Wei, Zarrin Basharat and Godwin C. Lang’at

DDC, 2024, 3, 54
DOI: 10.3390/ddc3010005

Exploring the treatment of SARS-CoV-2 with modified vesicular stomatitis virus

Nishnath Polavarapu, Madison Doty and Hana M. Dobrovolny

Journal of Theoretical Biology, 2024, 595, 111959
DOI: 10.1016/j.jtbi.2024.111959